A modified rosette inhibition test in renal allotransplantation.
The rosette inhibition test, with a modification of the technique which enables highly accurate marking of T lymphocytes, has been employed in the followup of 55 renal transplant patients. The minimal inhibitory concentration of antilymphocyte globulin (that is, that concentration of antilymphocyte globulin causing 25% inhibition of rosette formation) was higher than 1:16,000 in 63 (97%) of 65 separate determinations made during acute rejection episodes, and lower than 1:16,000 in 377 (92%) of 410 determinations after which no clinical evidence of rejection developed. The results presented in this paper indicate that this modified test is a useful tool either to predict the occurrence of or to confirm the diagnosis of rejection.
D000038:Abscess / Q000276:immunology; D000818:Animals; D000961:Antilymphocyte Serum; D004912:Erythrocytes / Q000276:immunology; D006084:Graft Rejection; D006801:Humans; D007104:Immune Adherence Reaction / Q000379:methods*; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology; D011014:Pneumonia / Q000276:immunology; D018805:Sepsis / Q000276:immunology; D012756:Sheep / Q000276:immunology; D014184:Transplantation, Homologous; D014552:Urinary Tract Infections / Q000276:immunology
D000961:Antilymphocyte Serum